No results for ‘’
Jagsonpal Pharmaceuticals Ltd
NSE: JAGSNPHARM BSE: 507789
₹212.28
(0.82%)
Tue, 23 Jun 2026, 02:31 am
Market Cap (in Cr)1425.7
PE Ratio33.47
Dividend1.18
Jagsonpal Pharmaceuticals Ltd About
Jagsonpal Pharmaceuticals engaged in the business of manufacturing and trading of pharmaceutical products and active pharmaceutical ingredients.
Industry
Pharmaceuticals - Indian - Bulk Drugs & Formln
Founded
1978
Headquarters
CEO
Harsha Raghavan
Employees
Contact
Website
http://www.jagsonpal.com
skmata@jagsonpal.com; cs@jagsonpal.com
Phone
91-011-46181100/46109900
Location
T-210 J, Shahpur Jat, New Delhi, New Delhi, 110049